Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


NHS mid-life health checks to include dementia risk

Dementia risk will now be included as part of the NHS Health Check programme, Public Health England (PHE) has announced.

Adding dementia risk to the NHS Health Check programme for patients aged 40–74 years will mean healthcare professionals can “talk to their patients about how they can reduce their dementia risk, such as by maintaining their social life, keeping mentally and physically active and stopping smoking”, PHE said.

More than 850,000 people are living with dementia in the UK with little public understanding of the risk factors. PHE said that while much of the NHS Health Check focuses on reducing cardiovascular disease (CVD) risk, the advice for preventing CVD is much the same as for dementia, and that “what’s good for the heart is good for the brain”.

Duncan Selbie, chief executive of PHE, said the NHS Health Check was one of the largest public health prevention programmes in the world, with almost seven million people having benefitted from it in the past five years, and the greatest numbers seen in the most disadvantaged areas. 

“It’s free, fast and effective — just 15 minutes, which could add years to your life,” he said.

The most recent five-year performance of the NHS Health Check found that over 14 million people (91% of the five-year eligible population) had been offered an NHS Health Check, and almost 7 million (48.7% of those offered) had had one.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205021

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Dementia patient

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.